Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Applied Therapeutics Inc. (APLT)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 114,850,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of product candidates against validated molecular targets in indications of high unmet medical need. AT-007 is a central nervous system penetrant ARI that Co. is developing for the treatment of metabolic diseases, including Galactosemia, a pediatric metabolic disease that affects how the body processes a simple sugar called galactose. AT-001 is an ARI with systemic exposure and peripheral nerve permeability that Co. is developing for the treatment of diabetic cardiomyopathy. AT-003 is an ARI designed to cross through the back of the eye when dosed orally for the treatment of diabetic retinopathy.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 30,000
Total Buy Value $0 $0 $0 $65,367
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 0 162,460 975,685 2,601,238
Total Sell Value $0 $94,798 $5,017,957 $11,187,643
Total People Sold 0 3 4 7
Total Sell Transactions 0 6 11 30
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 269
  Page 1 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bailey Evan Prescott Chief Medical Officer   •       –      –    2025-06-15 3 IO $0.00 $0 D/D 0 541,669     -
   Bailey Evan Prescott Chief Medical Officer   •       –      –    2025-06-15 4 A $0.00 $0 D/D 300,000 841,669     -
   Funtleyder Leslie D. See Remarks   •       •      –    2025-03-04 4 S $0.44 $6,381 D/D (14,502) 390,459     -
   Chinoporos Constantine See Remarks   •       –      –    2025-03-04 4 S $0.44 $197 D/D (447) 271,436     -
   Perfetti Riccardo Chief Medical Officer   •       –      –    2025-03-04 4 S $0.44 $4,561 D/D (10,366) 890,409     -
   Chinoporos Constantine See Remarks   •       –      –    2025-02-06 4 S $0.61 $17,151 D/D (28,117) 271,883     -
   Funtleyder Leslie D. See Remarks   •       •      –    2025-02-06 4 S $0.61 $14,000 D/D (22,950) 404,961     -
   Perfetti Riccardo Chief Medical Officer   •       –      –    2025-02-06 4 S $0.61 $52,508 D/D (86,078) 900,775     -
   Funtleyder Leslie D. See Remarks   •       •      –    2024-12-19 4 A $0.00 $0 D/D 150,000 427,911     -
   Johnson John H Executive Chairman   •       •      –    2024-12-19 4 A $0.00 $0 D/D 500,000 500,000     -
   Funtleyder Leslie D. Chief Financial Officer   •       •      –    2024-08-22 4 S $5.83 $78,880 D/D (13,530) 277,911     -
   Perfetti Riccardo Chief Medical Officer   •       –      –    2024-08-22 4 S $5.83 $132,230 D/D (22,681) 986,853     -
   Shendelman Shoshana President and CEO   •       •      –    2024-08-14 4 S $5.93 $709,175 D/D (119,591) 4,690,839     -
   Shendelman Shoshana President and CEO   •       •      –    2024-08-13 4 S $6.18 $2,208,874 D/D (357,423) 4,810,430     -
   Shendelman Shoshana President and CEO   •       •      –    2024-08-12 4 S $5.98 $1,794,000 D/D (300,000) 5,167,853     -
   Shendelman Shoshana President and CEO   •       •      –    2024-08-05 4 GA $0.00 $0 I/I 747,886 747,886     -
   Shendelman Shoshana President and CEO   •       •      –    2024-08-05 4 GD $0.00 $0 I/I 747,886 0     -
   Shendelman Shoshana President and CEO   •       •       •   2024-06-06 4 S $4.32 $266,954 D/D (61,795) 3,756,019     -
   Perfetti Riccardo Chief Medical Officer   •       –      –    2024-06-06 4 S $4.32 $95,053 D/D (22,003) 1,009,534     -
   Funtleyder Leslie D. Chief Financial Officer   •       •      –    2024-06-06 4 S $4.32 $73,354 D/D (16,980) 291,441     -
   Skyler Jay S   –       •      –    2024-06-06 4 A $0.00 $0 D/D 45,000 65,000     -
   Marcus Joel S   –       •      –    2024-06-06 4 A $0.00 $0 D/D 45,000 498,414     -
   Kanter Stacy J.   –       •      –    2024-06-06 4 A $0.00 $0 D/D 45,000 108,000     -
   Lerner Teena   –       •      –    2024-06-06 4 A $0.00 $0 D/D 45,000 105,422     -
   Alexandria Equities No. 7, Llc 10% Owner   –       –       •   2024-06-05 4 S $4.24 $636,000 I/I (150,000) 5,855,077     -
  269 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us